maytenus senegalensis
Botanicalexperimental
Clinical trial activity
2 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2015 (NCT01408849)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- maytenus ilicifolia leaves
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04944966 | Phase 2 | Jun 2, 2021 | Ifakara Health Institute, Muhimbili University, National Institute for Medical Research, Tanzania, University of Basel |
| NCT01408849 | Phase 2 | Feb 1, 2015 | Casa Espirita Terra de Ismael, University of Ribeirao Preto, University of Sao Paulo |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Casa Espirita Terra de Ismael | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Ifakara Health Institute | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Muhimbili University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| National Institute for Medical Research, Tanzania | Government | 1 | 0 | 1 | 2021 |
| University of Basel | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Ribeirao Preto | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Sao Paulo | Academic/Hospital | 1 | 0 | 1 | 2015 |
7 organizations
Page 1 / 1